Two jabs that each contained 1/4 of standard dose of Moderna  gave rise to long-lasting protective antibodies and virus-fighting T cells. The results hint at possibility of administering fractional doses to stretch limited vaccine supplies.

https://t.co/T2bKaLmWdB